Othmar Moser, Dessi Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M Bracken, Bruce A Buckingham, Thomas Danne, Elizabeth A Davis, Klemen Dovc, Gregory P Forlenza, Pieter Gillard, Sabine E Hofer, Roman Hovorka, Peter J Jacobs, Julia K Mader, Chantal Mathieu, Kirsten Nørgaard, Nick S Oliver, David N O'Neal, John Pemberton, Remi Rabasa-Lhoret, Jennifer L Sherr, Harald Sourij, Martin Tauschmann, Jane E Yardley, Michael C Riddell
{"title":"1型糖尿病患者在体育活动和运动中使用自动胰岛素输送:欧洲糖尿病研究协会(EASD)和国际儿科和青少年糖尿病学会(ISPAD)的立场声明","authors":"Othmar Moser, Dessi Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M Bracken, Bruce A Buckingham, Thomas Danne, Elizabeth A Davis, Klemen Dovc, Gregory P Forlenza, Pieter Gillard, Sabine E Hofer, Roman Hovorka, Peter J Jacobs, Julia K Mader, Chantal Mathieu, Kirsten Nørgaard, Nick S Oliver, David N O'Neal, John Pemberton, Remi Rabasa-Lhoret, Jennifer L Sherr, Harald Sourij, Martin Tauschmann, Jane E Yardley, Michael C Riddell","doi":"10.1159/000542287","DOIUrl":null,"url":null,"abstract":"<p><p>Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provides additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on its use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.</p>","PeriodicalId":13025,"journal":{"name":"Hormone Research in Paediatrics","volume":" ","pages":"1-28"},"PeriodicalIF":2.6000,"publicationDate":"2024-12-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).\",\"authors\":\"Othmar Moser, Dessi Zaharieva, Peter Adolfsson, Tadej Battelino, Richard M Bracken, Bruce A Buckingham, Thomas Danne, Elizabeth A Davis, Klemen Dovc, Gregory P Forlenza, Pieter Gillard, Sabine E Hofer, Roman Hovorka, Peter J Jacobs, Julia K Mader, Chantal Mathieu, Kirsten Nørgaard, Nick S Oliver, David N O'Neal, John Pemberton, Remi Rabasa-Lhoret, Jennifer L Sherr, Harald Sourij, Martin Tauschmann, Jane E Yardley, Michael C Riddell\",\"doi\":\"10.1159/000542287\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provides additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on its use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.</p>\",\"PeriodicalId\":13025,\"journal\":{\"name\":\"Hormone Research in Paediatrics\",\"volume\":\" \",\"pages\":\"1-28\"},\"PeriodicalIF\":2.6000,\"publicationDate\":\"2024-12-10\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hormone Research in Paediatrics\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1159/000542287\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"ENDOCRINOLOGY & METABOLISM\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hormone Research in Paediatrics","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000542287","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ENDOCRINOLOGY & METABOLISM","Score":null,"Total":0}
The Use of Automated Insulin Delivery around Physical Activity and Exercise in Type 1 Diabetes: A Position Statement of the European Association for the Study of Diabetes (EASD) and the International Society for Pediatric and Adolescent Diabetes (ISPAD).
Regular physical activity and exercise (PA) are cornerstones of diabetes care for individuals with type 1 diabetes. In recent years, the availability of automated insulin delivery (AID) systems has improved the ability of people with type 1 diabetes to achieve the recommended glucose target ranges. PA provides additional health benefits but can cause glucose fluctuations, which challenges current AID systems. While an increasing number of clinical trials and reviews are being published on different AID systems and PA, it seems prudent at this time to collate this information and develop a position statement on the topic. This joint European Association for the Study of Diabetes (EASD)/International Society for Pediatric and Adolescent Diabetes (ISPAD) position statement reviews current evidence on AID systems and provides detailed clinical practice points for managing PA in children, adolescents and adults with type 1 diabetes using AID technology. It discusses each commercially available AID system individually and provides guidance on its use in PA. Additionally, it addresses different glucose responses to PA and provides stratified therapy options to maintain glucose levels within the target ranges for these age groups.
期刊介绍:
The mission of ''Hormone Research in Paediatrics'' is to improve the care of children with endocrine disorders by promoting basic and clinical knowledge. The journal facilitates the dissemination of information through original papers, mini reviews, clinical guidelines and papers on novel insights from clinical practice. Periodic editorials from outstanding paediatric endocrinologists address the main published novelties by critically reviewing the major strengths and weaknesses of the studies.